Cargando…
The effects of trastuzumab on HER2-mediated cell signaling in CHO cells expressing human HER2
BACKGROUND: Targeted therapy with trastuzumab has become a mainstay for HER2-positive breast cancer without a clear understanding of the mechanism of its action. While many mechanisms have been suggested for the action of trastuzumab, most of them are not substantiated by experimental data. It has b...
Autores principales: | Maadi, Hamid, Nami, Babak, Tong, Junfeng, Li, Gina, Wang, Zhixiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5831215/ https://www.ncbi.nlm.nih.gov/pubmed/29490608 http://dx.doi.org/10.1186/s12885-018-4143-x |
Ejemplares similares
-
The Effects of Pertuzumab and Its Combination with Trastuzumab on HER2 Homodimerization and Phosphorylation
por: Nami, Babak, et al.
Publicado: (2019) -
Mechanisms Underlying the Action and Synergism of Trastuzumab and Pertuzumab in Targeting HER2-Positive Breast Cancer
por: Nami, Babak, et al.
Publicado: (2018) -
A Novel Mechanism Underlying the Inhibitory Effects of Trastuzumab on the Growth of HER2-Positive Breast Cancer Cells
por: Maadi, Hamid, et al.
Publicado: (2022) -
HER2 in Breast Cancer Stemness: A Negative Feedback Loop towards Trastuzumab Resistance
por: Nami, Babak, et al.
Publicado: (2017) -
Epigenetic Silencing of HER2 Expression during Epithelial-Mesenchymal Transition Leads to Trastuzumab Resistance in Breast Cancer
por: Nami, Babak, et al.
Publicado: (2021)